Discovery of zoniporide: A potent and selective sodium–hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility

• Published in: Bioorganic & medicinal chemistry letters 2001-03, Vol.11 (6), p.803-807
• Main Authors: Guzman-Perez, Angel, Wester, Ronald T., Allen, Mary C., Brown, Janice A., Buchholz, Allan R., Cook, Ewell R., Day, Wesley W., Hamanaka, Ernest S., Kennedy, Scott P., Knight, Delvin R., Kowalczyk, Paul J., Marala, Ravi B., Mularski, Christian J., Novomisle, William A., Ruggeri, Roger B., Tracey, W.Ross, Hill, Roger J.
• Format: Article
• Language: English
• Subjects: Animals; Biological and medical sciences; Cardiovascular system; Dogs; Guanidines - chemistry; Guanidines - pharmacokinetics; Guanidines - pharmacology; Injections, Intravenous; Medical sciences; Miscellaneous; Molecular Conformation; Pharmacology. Drug treatments; Protective Agents - pharmacokinetics; Protective Agents - pharmacology; Pyrazoles - chemistry; Pyrazoles - pharmacokinetics; Pyrazoles - pharmacology; Rats; Sodium-Hydrogen Exchangers - antagonists & inhibitors; Sodium-Hydrogen Exchangers - metabolism; Solubility; Water - chemistry
• ISSN: 0960-894X; 1464-3405
• DOI: 10.1016/S0960-894X(01)00059-2

Zoniporide (CP-597,396) is a potent and selective inhibitor of NHE-1, which exhibits high aqueous solubility and acceptable pharmacokinetics for intravenous administration. The discovery, synthesis, activities, and rat and dog pharmacokinetics of this compound are presented. The potency and selectivity of zoniporide may be due to the conformation that the molecule adopts due to the presence of a cyclopropyl and a 5-quinolinyl substituent on the central pyrazole ring of the molecule. The discovery, synthesis, and activities of NHE-1 inhibitor zoniporide (CP-597,396) are presented.